Zota Health Care (ZOTA) | Financial Analysis & Statements
Zota Health Care Limited Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
1.0B
Gross Profit
584.5M
56.43%
Operating Income
-107.2M
-10.35%
Net Income
-137.8M
-13.30%
EPS (Diluted)
₹-4.92
Balance Sheet Metrics
Total Assets
4.4B
Total Liabilities
2.1B
Shareholders Equity
2.3B
Debt to Equity
0.93
Cash Flow Metrics
Operating Cash Flow
-8.6M
Free Cash Flow
41.9M
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Zota Health Care Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.9B | 1.8B | 1.4B | 1.3B | 1.1B |
| Cost of Goods Sold | 1.4B | 1.0B | 848.3M | 893.1M | 757.5M |
| Gross Profit | 1.5B | 803.4M | 551.3M | 418.9M | 310.4M |
| Gross Margin % | 51.0% | 44.5% | 39.4% | 31.9% | 29.1% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | 0 |
| Selling, General & Administrative | 652.3M | 412.8M | 340.9M | 159.6M | 201.8M |
| Other Operating Expenses | 13.1M | 5.5M | 3.3M | 2.0M | 1.6M |
| Total Operating Expenses | 665.3M | 418.3M | 344.2M | 161.6M | 203.4M |
| Operating Income | -480.9M | -126.1M | -38.3M | 112.0M | -21.5M |
| Operating Margin % | -16.4% | -7.0% | -2.7% | 8.5% | -2.0% |
| Non-Operating Items | |||||
| Interest Income | 17.1M | 9.5M | 8.8M | 13.2M | 7.2M |
| Interest Expense | 89.7M | 42.0M | 24.9M | 2.6M | 504.0K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -576.4M | -161.6M | -46.9M | 124.3M | -3.7M |
| Income Tax | -9.1M | -18.2M | 10.8M | 35.3M | -1.6M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 28.4% | 0.0% |
| Net Income | -567.4M | -143.5M | -57.7M | 89.1M | -2.1M |
| Net Margin % | -19.4% | -7.9% | -4.1% | 6.8% | -0.2% |
| Key Metrics | |||||
| EBITDA | -42.2M | 82.1M | 92.1M | 163.6M | 18.2M |
| EPS (Basic) | ₹-20.68 | ₹-5.59 | ₹-2.29 | ₹3.58 | ₹-0.09 |
| EPS (Diluted) | ₹-20.68 | ₹-5.59 | ₹-2.29 | ₹3.58 | ₹-0.09 |
| Basic Shares Outstanding | 27268929 | 25644606 | 25160327 | 24884163 | 24560327 |
| Diluted Shares Outstanding | 27268929 | 25644606 | 25160327 | 24884163 | 24560327 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Zota Health Care Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 21.3M | 6.8M | 919.0K | 383.0K | 152.0K |
| Short-term Investments | 14.9M | 3.3M | 10.2M | 22.6M | 13.3M |
| Accounts Receivable | 405.0M | 272.4M | 278.3M | 363.7M | 287.7M |
| Inventory | 1.1B | 537.7M | 417.9M | 289.5M | 281.8M |
| Other Current Assets | 2.0K | 1.0K | 1.0K | -1.0K | -1.0K |
| Total Current Assets | 1.8B | 1.1B | 841.7M | 769.0M | 612.1M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 65.2M | 3.8M | 3.8M | 3.8M | 3.8M |
| Goodwill | 49.2M | 40.7M | 42.9M | 54.7M | 64.7M |
| Intangible Assets | 49.2M | 40.7M | 42.9M | 54.7M | 64.7M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | -1.0K | -1.0K | -1.0K | -2.0K | -2.0K |
| Total Non-Current Assets | 2.5B | 1.2B | 739.4M | 621.9M | 242.6M |
| Total Assets | 4.4B | 2.3B | 1.6B | 1.4B | 854.7M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 424.0M | 336.1M | 264.6M | 187.0M | 156.0M |
| Short-term Debt | 320.5M | 321.2M | 88.6M | 24.4M | 0 |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 16.8M | 8.8M | 5.3M | 4.1M | 1.1M |
| Total Current Liabilities | 1.0B | 736.8M | 405.2M | 359.6M | 182.3M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.1B | 631.6M | 362.6M | 124.6M | 0 |
| Deferred Tax Liabilities | 0 | - | - | - | 67.0K |
| Other Non-Current Liabilities | 1.0K | 1.0K | - | 2.0K | 1.0K |
| Total Non-Current Liabilities | 1.1B | 646.7M | 372.4M | 135.1M | 9.4M |
| Total Liabilities | 2.1B | 1.4B | 777.6M | 494.7M | 191.7M |
| Equity | |||||
| Common Stock | 286.4M | 258.5M | 251.6M | 251.6M | 245.6M |
| Retained Earnings | -191.9M | 658.8M | 457.5M | 187.1M | 121.8M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 2.3B | 899.8M | 803.6M | 896.3M | 663.0M |
| Key Metrics | |||||
| Total Debt | 1.4B | 952.8M | 451.2M | 149.0M | 0 |
| Working Capital | 835.5M | 379.3M | 436.5M | 409.4M | 429.8M |
Balance Sheet Composition
Zota Health Care Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -576.4M | -161.6M | -46.9M | 124.3M | -3.7M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 5.9M | 3.5M | 0 | - | - |
| Working Capital Changes | -511.0M | -502.1M | -298.0M | -30.9M | -26.6M |
| Operating Cash Flow | -1.0B | -627.7M | -333.3M | 83.3M | -37.2M |
| Investing Activities | |||||
| Capital Expenditures | -459.7M | -166.1M | -113.6M | -32.5M | -8.4M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | - | - | -248.4M | - |
| Investment Sales | - | - | - | - | 40.4M |
| Investing Cash Flow | -459.7M | -166.1M | -113.6M | -280.9M | 31.9M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -27.4M | -25.8M | -37.7M | -25.2M | -24.6M |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | -140.7M | - | -17.2M | -11.4M | -498.0K |
| Financing Cash Flow | 1.6B | 381.8M | -54.9M | 150.4M | -24.1M |
| Free Cash Flow | -959.4M | -226.9M | -145.1M | 100.8M | -28.2M |
| Net Change in Cash | 113.4M | -412.0M | -501.8M | -47.1M | -29.3M |
Cash Flow Trend
Zota Health Care Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-62.53
Price to Book
12.61
Price to Sales
8.34
PEG Ratio
-0.59
Profitability Ratios
Profit Margin
-15.37%
Operating Margin
-15.88%
Return on Equity
-24.83%
Return on Assets
-12.84%
Financial Health
Current Ratio
1.83
Debt to Equity
56.90
Beta
0.36
Per Share Data
EPS (TTM)
₹-23.94
Book Value per Share
₹103.04
Revenue per Share
₹157.02
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ZOTA | 39.4B | -62.53 | 12.61 | -24.83% | -15.37% | 56.90 |
| Biocon | 566.5B | 71.84 | 1.68 | 3.66% | 3.59% | 50.02 |
| OneSource Specialty | 202.8B | 936.63 | 3.11 | -0.31% | 1.42% | 21.93 |
| Dishman Carbogen | 26.5B | 22.30 | 0.42 | 0.06% | 4.25% | 40.20 |
| Panacea Biotec | 21.8B | 182.62 | 2.65 | -1.01% | -1.29% | 2.79 |
| Titan Bio-Tech | 19.9B | 74.64 | 12.19 | 14.04% | 14.13% | 5.32 |
Financial data is updated regularly. All figures are in the company's reporting currency.





